Eversept Partners, LP Solid Biosciences Inc. Transaction History

Eversept Partners, LP

  • $1.32 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.08 - $7.79 $945,633 - $2.39 Million
-307,024 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$2.02 - $3.08 $202,000 - $308,000
-100,000 Reduced 24.57%
307,024 $623,000
Q2 2020

Nov 08, 2023
BUY
$2.1 - $3.42 $854,750 - $1.39 Million
407,024 New
407,024 $1.19 Million
Q2 2020

Aug 13, 2020
BUY
$2.1 - $3.42 $854,750 - $1.39 Million
407,024 New
407,024 $1.19 Million

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email